BHOC Perspective · Tissue oxygenation · Hemoglobin · HBOC

Tissue oxygenation, hemoglobin and HBOC

Hemoglobin concentration and blood oxygen content are not the same as effective tissue oxygenation.

This indexed summary uses a peer-reviewed hemoglobin physiology study to examine a broader question relevant to HBOC and BHOC research: how oxygen carriage, blood flow and microcirculatory regulation together determine tissue oxygenation.

Peer-reviewed evidence

What the 2015 PNAS study showed

Zhang and colleagues studied mice carrying a βCys93Ala hemoglobin mutation. The mutation did not remove hemoglobin's basic oxygen-carrying function, but it impaired hypoxic vasodilation, reduced peripheral blood flow and tissue oxygenation, and was associated with myocardial ischemia and worse adaptation to transient hypoxia.

The authors interpreted βCys93-derived S-nitrosothiol bioactivity as an important component of red-cell-mediated regulation of blood flow and tissue oxygenation.

Reference: Zhang R, Hess DT, Qian Z, et al. Hemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia. PNAS. 2015;112(20):6425-6430. DOI: 10.1073/pnas.1502285112.

Scientific context: This page owns the tissue oxygenation, hemoglobin and HBOC discussion. Detailed NO-scavenging and vasoconstriction evidence is maintained on the dedicated BHOC Science page. This page does not establish a clinical indication.